Global Enterobacteriaceae Infection Drug Market Research Report 2023

Report ID: 1891912 | Published Date: Oct 2024 | No. of Page: 87 | Base Year: 2023 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Enterobacteriaceae Infection Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Beta-lactams Drugs
        1.2.3 Carbapenems Drugs
        1.2.4 Fluoroquinolones Drugs
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Enterobacteriaceae Infection Drug Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Enterobacteriaceae Infection Drug Market Perspective (2017-2028)
    2.2 Enterobacteriaceae Infection Drug Growth Trends by Region
        2.2.1 Enterobacteriaceae Infection Drug Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Enterobacteriaceae Infection Drug Historic Market Size by Region (2017-2022)
        2.2.3 Enterobacteriaceae Infection Drug Forecasted Market Size by Region (2023-2028)
    2.3 Enterobacteriaceae Infection Drug Market Dynamics
        2.3.1 Enterobacteriaceae Infection Drug Industry Trends
        2.3.2 Enterobacteriaceae Infection Drug Market Drivers
        2.3.3 Enterobacteriaceae Infection Drug Market Challenges
        2.3.4 Enterobacteriaceae Infection Drug Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Enterobacteriaceae Infection Drug Players by Revenue
        3.1.1 Global Top Enterobacteriaceae Infection Drug Players by Revenue (2017-2022)
        3.1.2 Global Enterobacteriaceae Infection Drug Revenue Market Share by Players (2017-2022)
    3.2 Global Enterobacteriaceae Infection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Enterobacteriaceae Infection Drug Revenue
    3.4 Global Enterobacteriaceae Infection Drug Market Concentration Ratio
        3.4.1 Global Enterobacteriaceae Infection Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Enterobacteriaceae Infection Drug Revenue in 2021
    3.5 Enterobacteriaceae Infection Drug Key Players Head office and Area Served
    3.6 Key Players Enterobacteriaceae Infection Drug Product Solution and Service
    3.7 Date of Enter into Enterobacteriaceae Infection Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Enterobacteriaceae Infection Drug Breakdown Data by Type
    4.1 Global Enterobacteriaceae Infection Drug Historic Market Size by Type (2017-2022)
    4.2 Global Enterobacteriaceae Infection Drug Forecasted Market Size by Type (2023-2028)
5 Enterobacteriaceae Infection Drug Breakdown Data by Application
    5.1 Global Enterobacteriaceae Infection Drug Historic Market Size by Application (2017-2022)
    5.2 Global Enterobacteriaceae Infection Drug Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Enterobacteriaceae Infection Drug Market Size (2017-2028)
    6.2 North America Enterobacteriaceae Infection Drug Market Size by Country (2017-2022)
    6.3 North America Enterobacteriaceae Infection Drug Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Enterobacteriaceae Infection Drug Market Size (2017-2028)
    7.2 Europe Enterobacteriaceae Infection Drug Market Size by Country (2017-2022)
    7.3 Europe Enterobacteriaceae Infection Drug Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Enterobacteriaceae Infection Drug Market Size (2017-2028)
    8.2 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Country (2017-2022)
    8.3 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Enterobacteriaceae Infection Drug Market Size (2017-2028)
    9.2 Latin America Enterobacteriaceae Infection Drug Market Size by Country (2017-2022)
    9.3 Latin America Enterobacteriaceae Infection Drug Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Enterobacteriaceae Infection Drug Market Size (2017-2028)
    10.2 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2017-2022)
    10.3 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Genentech
        11.1.1 Genentech Company Detail
        11.1.2 Genentech Business Overview
        11.1.3 Genentech Enterobacteriaceae Infection Drug Introduction
        11.1.4 Genentech Revenue in Enterobacteriaceae Infection Drug Business (2017-2022)
        11.1.5 Genentech Recent Development
    11.2 Nanotherapeutics
        11.2.1 Nanotherapeutics Company Detail
        11.2.2 Nanotherapeutics Business Overview
        11.2.3 Nanotherapeutics Enterobacteriaceae Infection Drug Introduction
        11.2.4 Nanotherapeutics Revenue in Enterobacteriaceae Infection Drug Business (2017-2022)
        11.2.5 Nanotherapeutics Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Detail
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Enterobacteriaceae Infection Drug Introduction
        11.3.4 Novartis Revenue in Enterobacteriaceae Infection Drug Business (2017-2022)
        11.3.5 Novartis Recent Development
    11.4 Pfizer
        11.4.1 Pfizer Company Detail
        11.4.2 Pfizer Business Overview
        11.4.3 Pfizer Enterobacteriaceae Infection Drug Introduction
        11.4.4 Pfizer Revenue in Enterobacteriaceae Infection Drug Business (2017-2022)
        11.4.5 Pfizer Recent Development
    11.5 Nymox Pharmaceutical
        11.5.1 Nymox Pharmaceutical Company Detail
        11.5.2 Nymox Pharmaceutical Business Overview
        11.5.3 Nymox Pharmaceutical Enterobacteriaceae Infection Drug Introduction
        11.5.4 Nymox Pharmaceutical Revenue in Enterobacteriaceae Infection Drug Business (2017-2022)
        11.5.5 Nymox Pharmaceutical Recent Development
    11.6 Sequoia Sciences
        11.6.1 Sequoia Sciences Company Detail
        11.6.2 Sequoia Sciences Business Overview
        11.6.3 Sequoia Sciences Enterobacteriaceae Infection Drug Introduction
        11.6.4 Sequoia Sciences Revenue in Enterobacteriaceae Infection Drug Business (2017-2022)
        11.6.5 Sequoia Sciences Recent Development
    11.7 Phico Therapeutics
        11.7.1 Phico Therapeutics Company Detail
        11.7.2 Phico Therapeutics Business Overview
        11.7.3 Phico Therapeutics Enterobacteriaceae Infection Drug Introduction
        11.7.4 Phico Therapeutics Revenue in Enterobacteriaceae Infection Drug Business (2017-2022)
        11.7.5 Phico Therapeutics Recent Development
    11.8 Cantab Biopharmaceuticals
        11.8.1 Cantab Biopharmaceuticals Company Detail
        11.8.2 Cantab Biopharmaceuticals Business Overview
        11.8.3 Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Introduction
        11.8.4 Cantab Biopharmaceuticals Revenue in Enterobacteriaceae Infection Drug Business (2017-2022)
        11.8.5 Cantab Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Enterobacteriaceae Infection Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Beta-lactams Drugs
    Table 3. Key Players of Carbapenems Drugs
    Table 4. Key Players of Fluoroquinolones Drugs
    Table 5. Key Players of Others
    Table 6. Global Enterobacteriaceae Infection Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Enterobacteriaceae Infection Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Enterobacteriaceae Infection Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Enterobacteriaceae Infection Drug Market Share by Region (2017-2022)
    Table 10. Global Enterobacteriaceae Infection Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Enterobacteriaceae Infection Drug Market Share by Region (2023-2028)
    Table 12. Enterobacteriaceae Infection Drug Market Trends
    Table 13. Enterobacteriaceae Infection Drug Market Drivers
    Table 14. Enterobacteriaceae Infection Drug Market Challenges
    Table 15. Enterobacteriaceae Infection Drug Market Restraints
    Table 16. Global Enterobacteriaceae Infection Drug Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Enterobacteriaceae Infection Drug Market Share by Players (2017-2022)
    Table 18. Global Top Enterobacteriaceae Infection Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enterobacteriaceae Infection Drug as of 2021)
    Table 19. Ranking of Global Top Enterobacteriaceae Infection Drug Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Enterobacteriaceae Infection Drug Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Enterobacteriaceae Infection Drug Product Solution and Service
    Table 23. Date of Enter into Enterobacteriaceae Infection Drug Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Enterobacteriaceae Infection Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Enterobacteriaceae Infection Drug Revenue Market Share by Type (2017-2022)
    Table 27. Global Enterobacteriaceae Infection Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Enterobacteriaceae Infection Drug Revenue Market Share by Type (2023-2028)
    Table 29. Global Enterobacteriaceae Infection Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Enterobacteriaceae Infection Drug Revenue Market Share by Application (2017-2022)
    Table 31. Global Enterobacteriaceae Infection Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Enterobacteriaceae Infection Drug Revenue Market Share by Application (2023-2028)
    Table 33. North America Enterobacteriaceae Infection Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Enterobacteriaceae Infection Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Enterobacteriaceae Infection Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Enterobacteriaceae Infection Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Enterobacteriaceae Infection Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Enterobacteriaceae Infection Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Genentech Company Detail
    Table 44. Genentech Business Overview
    Table 45. Genentech Enterobacteriaceae Infection Drug Product
    Table 46. Genentech Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million)
    Table 47. Genentech Recent Development
    Table 48. Nanotherapeutics Company Detail
    Table 49. Nanotherapeutics Business Overview
    Table 50. Nanotherapeutics Enterobacteriaceae Infection Drug Product
    Table 51. Nanotherapeutics Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million)
    Table 52. Nanotherapeutics Recent Development
    Table 53. Novartis Company Detail
    Table 54. Novartis Business Overview
    Table 55. Novartis Enterobacteriaceae Infection Drug Product
    Table 56. Novartis Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million)
    Table 57. Novartis Recent Development
    Table 58. Pfizer Company Detail
    Table 59. Pfizer Business Overview
    Table 60. Pfizer Enterobacteriaceae Infection Drug Product
    Table 61. Pfizer Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million)
    Table 62. Pfizer Recent Development
    Table 63. Nymox Pharmaceutical Company Detail
    Table 64. Nymox Pharmaceutical Business Overview
    Table 65. Nymox Pharmaceutical Enterobacteriaceae Infection Drug Product
    Table 66. Nymox Pharmaceutical Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million)
    Table 67. Nymox Pharmaceutical Recent Development
    Table 68. Sequoia Sciences Company Detail
    Table 69. Sequoia Sciences Business Overview
    Table 70. Sequoia Sciences Enterobacteriaceae Infection Drug Product
    Table 71. Sequoia Sciences Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million)
    Table 72. Sequoia Sciences Recent Development
    Table 73. Phico Therapeutics Company Detail
    Table 74. Phico Therapeutics Business Overview
    Table 75. Phico Therapeutics Enterobacteriaceae Infection Drug Product
    Table 76. Phico Therapeutics Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million)
    Table 77. Phico Therapeutics Recent Development
    Table 78. Cantab Biopharmaceuticals Company Detail
    Table 79. Cantab Biopharmaceuticals Business Overview
    Table 80. Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Product
    Table 81. Cantab Biopharmaceuticals Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million)
    Table 82. Cantab Biopharmaceuticals Recent Development
    Table 83. Research Programs/Design for This Report
    Table 84. Key Data Information from Secondary Sources
    Table 85. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Enterobacteriaceae Infection Drug Market Share by Type: 2021 VS 2028
    Figure 2. Beta-lactams Drugs Features
    Figure 3. Carbapenems Drugs Features
    Figure 4. Fluoroquinolones Drugs Features
    Figure 5. Others Features
    Figure 6. Global Enterobacteriaceae Infection Drug Market Share by Application in 2021 & 2028
    Figure 7. Hospital Pharmacies Case Studies
    Figure 8. Retail Pharmacies Case Studies
    Figure 9. Online Pharmacies Case Studies
    Figure 10. Enterobacteriaceae Infection Drug Report Years Considered
    Figure 11. Global Enterobacteriaceae Infection Drug Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Enterobacteriaceae Infection Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Enterobacteriaceae Infection Drug Market Share by Region: 2021 VS 2028
    Figure 14. Global Enterobacteriaceae Infection Drug Market Share by Players in 2021
    Figure 15. Global Top Enterobacteriaceae Infection Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enterobacteriaceae Infection Drug as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Enterobacteriaceae Infection Drug Revenue in 2021
    Figure 17. North America Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Enterobacteriaceae Infection Drug Market Share by Country (2017-2028)
    Figure 19. United States Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Enterobacteriaceae Infection Drug Market Share by Country (2017-2028)
    Figure 23. Germany Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Enterobacteriaceae Infection Drug Market Share by Region (2017-2028)
    Figure 31. China Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Enterobacteriaceae Infection Drug Market Share by Country (2017-2028)
    Figure 39. Mexico Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Enterobacteriaceae Infection Drug Market Share by Country (2017-2028)
    Figure 43. Turkey Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Genentech Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022)
    Figure 46. Nanotherapeutics Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022)
    Figure 47. Novartis Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022)
    Figure 48. Pfizer Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022)
    Figure 49. Nymox Pharmaceutical Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022)
    Figure 50. Sequoia Sciences Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022)
    Figure 51. Phico Therapeutics Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022)
    Figure 52. Cantab Biopharmaceuticals Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Genentech
Nanotherapeutics
Novartis
Pfizer
Nymox Pharmaceutical
Sequoia Sciences
Phico Therapeutics
Cantab Biopharmaceuticals
Frequently Asked Questions
Enterobacteriaceae Infection Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Enterobacteriaceae Infection Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Enterobacteriaceae Infection Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Elbow Replacement

Elbow Replacement market is segmented by players, region (country), by Type and by Application. P ... Read More